Sofosbuvir as repurposed antiviral drug against COVID-19: why were we convinced to evaluate the drug in a registered/approved clinical trial?

B Sayad, M Sobhani, R Khodarahmi - Archives of medical research, 2020 - Elsevier
COVID-19 is a devastating global pandemic around the world. While the majority of infected
cases appear mild, in some cases individuals present respiratory complications with …
被引用次数：78 相关文章
[HTML] nih.gov

[HTML][HTML] Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?

B Sayad, M Sobhani, R Khodarahmi - Archives of Medical …, 2020 - ncbi.nlm.nih.gov
COVID-19 is a devastating global pandemic around the world. While the majority of infected
cases appear mild, in some cases individuals present respiratory complications with …

Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?

B Sayad, M Sobhani… - Archives of medical …, 2020 - pubmed.ncbi.nlm.nih.gov
COVID-19 is a devastating global pandemic around the world. While the majority of infected
cases appear mild, in some cases individuals present respiratory complications with …

Sofosbuvir as repurposed antiviral drug against COVID-19: why were we convinced to evaluate the drug in a registered/approved clinical trial?

B Sayad, M Sobhani, R Khodarahmi - 2020 - cabidigitallibrary.org
COVID-19 is a devastating global pandemic around the world. While the majority of infected
cases appear mild, in some cases individuals present respiratory complications with …

Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?

B Sayad, M Sobhani, R Khodarahmi - Archives of Medical Research, 2020 - europepmc.org
COVID-19 is a devastating global pandemic around the world. While the majority of infected
cases appear mild, in some cases individuals present respiratory complications with …

Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?

B Sayad, M Sobhani, R Khodarahmi - Archives of Medical Research, 2020 - europepmc.org
COVID-19 is a devastating global pandemic around the world. While the majority of infected
cases appear mild, in some cases individuals present respiratory complications with …